Biotechnology company developing cancer immunotherapies and vaccines for infectious diseases, including COVID-19, malaria, dengue, and influenza
Biotechnology company developing cancer immunotherapies and vaccines for infectious diseases, including COVID-19, malaria, dengue, and influenza. Its vaccine research uses a proprietary self-amplifying RNA (replicon) platform; the company also conducts clinical-trial material manufacturing.